CytoDyn (CYDY) Research & Development (2009 - 2026)
CytoDyn's Research & Development came in at $3.6 million for fiscal Q4 2024 (quarter ended May 31, 2024), up 266.7% from $981,000 a year earlier and up 453.4% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Research & Development (2009 - 2026) Analysis & Trends
For FY2024 (ended May 31, 2024), CytoDyn's Research & Development was $7.24 million, up 175.1% from FY2023.
- Research & Development carries a five-year compound annual growth rate of -29.8% (FY2019 to FY2024).
- Going back by fiscal year, Research & Development was $2.63 million in FY2023 (-90.3%), $27.04 million in FY2022 (-49.4%), $53.4 million in FY2021 (+1.4%) and $52.64 million in FY2020 (+23.9%).
- The fiscal Q4 2024 figure represents the highest quarterly Research & Development since fiscal Q4 2022.
- Year-over-year, Research & Development increased in three of the last eight quarters, with growth averaging 101.7%.
- The fastest year-over-year change in Research & Development over five years came in fiscal Q2 2024 (growth of 687.6%), and the weakest in fiscal Q2 2023 (a decline of 98.2%).
- Business Quant data shows CYDY's Research & Development at $650,000 (Q3 2024), $1.08 million (Q2 2024) and $1.91 million (Q1 2024) in the three fiscal quarters before Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | CytoDyn | 334.50 Mn | 285.65 Mn | - | 4.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 4.52 Mn |
| May 31, 2026 | 15.68 Bn |
| Feb 28, 2026 | 4.65 Mn |
| Nov 30, 2025 | 3.30 Mn |
| Aug 31, 2025 | 3.23 Mn |
| May 31, 2025 | -3.23 Mn |
| Feb 28, 2025 | 2.49 Mn |
| Nov 30, 2024 | 1.41 Mn |
| Aug 31, 2024 | 24.05 Mn |
| May 31, 2024 | 3.60 Mn |
| Feb 29, 2024 | 650,000.00 |
| Nov 30, 2023 | 1.08 Mn |
| Aug 31, 2023 | 1.91 Mn |
| May 31, 2023 | 981,000.00 |
| Feb 28, 2023 | 938,000.00 |
| Nov 30, 2022 | 137,000.00 |
| Aug 31, 2022 | 576,000.00 |
| May 31, 2022 | 4.01 Mn |
| Feb 28, 2022 | 3.57 Mn |
| Nov 30, 2021 | 7.45 Mn |
API Access
CytoDyn Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();